SEC 13F Intelligence

Artia Global Partners LP / PCVX

Artia Global Partners LP’s Vaxcyte Inc Position

Does Artia Global Partners LP own Vaxcyte Inc (PCVX)? Not currently — the last reported position was 162.3K shares worth $13M in Q4 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$13M
Q4 2024
Shares
162.3K
% of Portfolio
+4.75%
Quarters Held
8
position exited

Position History PCVX

Reported value by quarter
Q1 ’23: $853,007Q1 ’23Q2 ’23: $2MQ2 ’23Q3 ’23: $2MQ3 ’23Q4 ’23: $2MQ4 ’23Q1 ’24: $5MQ1 ’24Q2 ’24: $6MQ2 ’24Q3 ’24: $9MQ3 ’24Q4 ’24: $13MQ4 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2024162.3K$13M+4.75%
Q3 202476.3K$9M+2.38%
Q2 202476.3K$6M+1.11%
Q1 202476.3K$5M+1.05%
Q4 202338.6K$2M+0.70%
Q3 202338.6K$2M+0.82%
Q2 202338.6K$2M+0.66%
Q1 202322.8K$853,007+0.32%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Artia Global Partners LP’s full portfolio or all institutional holders of PCVX.